1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Kenneth Palmer: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of Q-Griffithsin Intranasal Spray Q-Griffithsin 3.0, Q-Griffithsin 6.0 - COVID-19 Prevention | Phase 1 | Unknown | Kenneth Palmer | 24 | 2022-06-15 | 2022-07-05 |
| PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray Q-Griffithsin, Placebo - COVID-19 Prevention | Phase 1 | Completed | Kenneth Palmer | 18 | 2021-11-11 | 2022-04-29 |
COVID-19 (2) · Coronavirus Infections (1)
q-griffithsin (1)
United States (2)